Jensen Investment Management Inc. cut its holdings in shares of Waters Co. (NYSE:WAT - Free Report) by 7.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,412 shares of the medical instruments supplier's stock after selling 3,540 shares during the period. Jensen Investment Management Inc. owned approximately 0.07% of Waters worth $16,476,000 at the end of the most recent quarter.
A number of other large investors have also recently added to or reduced their stakes in the business. Bank of Jackson Hole Trust acquired a new stake in shares of Waters during the 4th quarter valued at $34,000. Fortitude Family Office LLC lifted its holdings in shares of Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 66 shares during the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after purchasing an additional 53 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Waters by 54.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock valued at $46,000 after purchasing an additional 44 shares during the period. Finally, R Squared Ltd purchased a new position in Waters in the 4th quarter worth about $63,000. 94.01% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
WAT has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their target price on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. Wells Fargo & Company raised their price objective on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research note on Thursday, February 13th. Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 target price on the stock in a research note on Friday, January 10th. Barclays raised Waters from an "underweight" rating to an "equal weight" rating and raised their target price for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. Finally, UBS Group upped their price target on Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research report on Thursday, February 13th. Eleven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Waters currently has an average rating of "Hold" and a consensus target price of $391.07.
Get Our Latest Stock Report on Waters
Waters Stock Performance
WAT traded down $7.90 during trading on Thursday, hitting $363.44. The stock had a trading volume of 462,795 shares, compared to its average volume of 437,734. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. Waters Co. has a 12 month low of $279.24 and a 12 month high of $423.56. The company has a 50 day simple moving average of $391.31 and a 200-day simple moving average of $370.98. The firm has a market cap of $21.59 billion, a PE ratio of 33.93, a P/E/G ratio of 3.79 and a beta of 1.00.
Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Analysts expect that Waters Co. will post 12.86 EPS for the current year.
Waters Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
